Adrenergic Downregulation in Critical Care: Molecular Mechanisms and Therapeutic Evidence

Clicks: 190
ID: 269690
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #12 of 18 articles by views in journal of cardiothoracic and vascular anesthesia

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Catecholamines remain the mainstay of therapy for acute cardiovascular dysfunction. However, adrenergic receptors quickly undergo desensitization and downregulation after prolonged stimulation. Moreover, prolonged exposure to high circulating catecholamines levels is associated with several adverse …
Reference Key
a2020journaladrenergic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Belletti A;Landoni G;Lomivorotov VV;Oriani A;Ajello S;;
Journal journal of cardiothoracic and vascular anesthesia
Year 2020
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/31839459
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine critical care down-regulation Vasoconstrictor Agents / therapeutic use pmid:31839459 doi:10.1053/j.jvca.2019.10.017 alessandro belletti giovanni landoni silvia ajello adrenergic agents* catecholamines shock*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.